The success of Biogen and Keryx are yet to be solidified, but the signs are looking good. Most US investors tend to overlook the biopharmaceutical industry, and now is the right time to get their attention. Investing on companies like Biogen and Keryx during this time is may be foolproof. Biogen is one of the industry's best performers while Keryx is on the rise to compete with big names without too much risk through creating profitable partnerships.Reference Links:
The Big Cure For 2013 - Research Report On Biogen Idec Inc. And Keryx Biopharmaceuticals Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.